Patent · US Active

Modified compound of andrographolide

US10717720B2 · kind B2 · utility

1Cited by

0References

13Claims

0Family size

Assignees

Heilongjiang Zhenbaodao Pharmaceutical Co, LTD · CN
Medshine Discovery Inc. · CN

Inventors

Haiying He · Shanghai, CN
Zhigan Jiang · Shanghai, CN
Jianhua XIA · Shanghai, CN
Jing Wang · Beijing, CN
Lixia Han · Shanghai, CN
Lihong Lan · Shanghai, CN
Hui Zhou · Shanghai, CN
Kunmin Lai · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Nov 22, 2016
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Nov 22, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.